Zenas Biopharma's Purchased 60,000: Insider Buy Deep Dive
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Analyze expense ratios and hidden costs for SP500 and Total Market funds in retirement to gauge impact on net performance.
28,597 articlesA biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...
Honeywell split its aerospace unit into a new company, and the initial market reaction gave investors plenty to study...
Bitcoin is near a sensitive juncture as funding conditions tighten and equities remain richly valued. The coming week...
As AI demand grows, one data-center play stands out for potential upside. This piece breaks down the catalysts, risks...
A new Morgan Stanley Research report argues that housing affordability unlikely return to pre-2022 levels as rates st...
When AI buzz dominates markets, smart investors look abroad for durable moats. This guide explains two international ...
Micron posts strong AI-driven memory demand and rising cloud bookings, while Apple relies on devices and services to ...
A new model from Google Gemini AI projects a bold Solana price target for 2026, highlighting infrastructure upgrades ...
As Agora releases Q4 2025 data, investors will watch API growth, customer momentum, and profitability signals. This g...
Adobe shares have a tough year, yet JPMorgan sees upside. A $420 year-end target hinges on improving ARR, rising RPO,...
As Brazil debates new export taxes, ECOW’s big distributions spotlight a yield that may hide political and commodity ...
America’s debt has surged to WWII-era levels even as growth accelerates. Here’s what the numbers show and why investo...